European equities traded in the US as American depositary receipts were rising late Monday morning, up 1.19% to 1,327.75 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and healthcare company Grifols (GRFS), which climbed 6.1% and 4%. They were followed by networking and telecoms company Ericsson (ERIC) and pharmaceutical giant Novo Nordisk (NVO), which added 3.2% and 2.5%, respectively.
The decliners from continental Europe were led by medical device maker Edap (EDAP) and hotel and accommodation search platform Trivago (TRVG), which fell 6.3% and 3.3% respectively.
From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical firm Adaptimmune Therapeutics (ADAP), which were rising 4.3% and 1.4% respectively.
The decliners from the UK and Ireland were led by Biodexa Pharmaceuticals (BDRX) and Mereo BioPharma (MREO), which lost 5.1% and 3.9% respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.